REVOLAX™ SUB-Q with Lidocaine(hyaluronic acid/lidocaine)
- Product: REVOLAX™ SUB-Q with Lidocaine
- Manufacturer: Across Co., LTD.
- Active Substance(s) : hyaluronic acid/lidocaine
- Strength: 24mg/ml, 3mg/ml
- Pack Size: 1-1.1ml prefilled syringe
- Accessories: Package insert, 2-25G needles
Revolax Sub Q with Lidocaine is a biodegradable, nonanimal-based hyaluronic acid (HA) dermal filler that is designed for deep subcutaneous layer filling. It has the advanced ability to mould and provide structural integrity for the skin and is long-lasting. It is specifically designed to treat areas affected by deep and severe wrinkles in areas like the chin, lips, nose, and the nasolabial regions. It is also ideal for use in the cheeks for volume augmentation.
Benefits of this Product
Buy Revolax Sub Q with Lidocaine to bring its volumizing and wrinkle-removing effects, which can last between 12 to 18 months because of this filler’s high-degree of cross-linking, to your patients. The product also tends to stay in place after deposition, as it has a low phase angle. The high viscoelastic nature of Revolax Sub Q means the filler enhances the augmentation procedure naturally and is able to maintain its shape well throughout its duration of action. Furthermore, it still permits some malleability so that the injected areas can be contoured in a way that is conductive to the optimal aesthetic outcome. The high concentration of hyaluronic acid at 24mg/ml means that Revolax Sub Q flows smoothly and consistently during the injection process; in fact, it only requires a regular extrusion force of 16N throughout the injection process to be expulsed.
Revolax Sub Q is made with cross-linked hyaluronic acid at a concentration of 24mg/ml. It also contains 0.3% lidocaine hydrochloride.
- Prepare the patient by sitting them in a comfortable semi-reclined position.
- Clean the skin with alcohol.
- A soft, white surgical pencil or marker can be used to indicate the area(s) to be treated.
- Attach the 25-gauge needle to the prefilled dermal filler syringe.
- Prime the needle by depressing the syringe plunger until a minute amount of filler material is visibly extruded at the tip of the needle.
- Be sure that the needle is tightly fixed to the syringe, so as to prevent the needle from detaching during the injection procedure.
- Revolax Sub Q with Lidocaine is designed to be deposited into the subcutaneous tissue. When injected into this layer, minimal to no resistance should be felt during product deposition or when the needle is advanced. The needle tip is also not visible when at this depth. Do not inject at the incorrect level; withdraw the needle to the skin insertion and retry injecting.
- The dermal filler should be injected with firm and constant pressure on the syringe plunger as the needle is pulled back in a linear direction; this known as retrograde injection. Release the plunger just before pulling the needle out of the skin to ensure that no product is deposited into the epidermis.
- You may compress the injected area with your thumb and first finger to smoothen out any palpable bumps of the filler material. However, this may increase the risk of swelling and bruising. Do not place excessive material into the treatment area, as this may result in an unnatural and unappealing appearance.
For more specific instructions on how to attach the needle to the syringe, please refer to the package insert provided with the product.
Revolax Sub Q should not be used in individuals that are pregnant or breastfeeding. Patients that are underage (i.e. under 18 years old), have past incidence(s) of hypersensitivity to hyaluronic acid and lidocaine, or a tendency to develop hypertrophic scars should also be excluded. Additionally, avoid using Revolax Sub Q with laser therapy, chemical peeling, and dermal abrasion treatments. Compromised areas with inflammation and infection should also be avoided.
The common side effects that come about because of the use of this filler are usually transient and mild; the effects are usually local injection reactions. As such, redness, pain, and swelling are not unusual side effects, but these tend to become less apparent over time. To minimize any secondary irritation at the injection area, the patient must refrain from rubbing the area. Furthermore, there is also the Tyndall effect, where a bluish discoloration appears due to overly superficial deposition of the hyaluronic acid filler material, that may concern some patients. Hyaluronidase can be used to adequately correct this side effect and any overcorrection that resulted from the initial treatment. Vascular compromise due to intravascular deposition of filler material have been reported, but these are rare occurrences. In any case, the patient must be informed of the risks and understand the implications of the filler.
Patients should be informed of all possible side effects prior to treatment. If any adverse effects are prolonged or worsen, your patient should contact you or another medical professional.